We evaluated the level of adiponectin in patients with ischemic HF, with and without type 2 diabetes, to elucidate whether the metabolic syndrome was able to influence the relationship between AD and HF. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.